LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for A2 Biotherapeutics, Inc. and Millions of Other Companies

Sign up for full access to A2 Biotherapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Cutting-Edge Cancer Therapies A2 Biotherapeutics is pioneering targeted cell therapies for cancer treatment, specifically focusing on solid tumors. This unique approach could present valuable sales opportunities for healthcare institutions seeking innovative treatment options for patients.

Experienced Leadership Team With the recent hiring of James Robinson as CEO, A2 Biotherapeutics has strengthened its leadership team. Leveraging the expertise of seasoned executives can enhance credibility and potentially attract partnerships with pharmaceutical companies looking to invest in promising biotech ventures.

Strategic Funding and Growth Having raised $136M in funding, A2 Biotherapeutics demonstrates financial stability and a commitment to growth. This solid financial foundation can instill confidence in potential investors and partners, opening up opportunities for strategic collaborations and joint ventures.

Innovative T-Cell Platform The development of the Tmod platform by A2 Biotherapeutics showcases their innovative approach to T-cell therapy. This technology, designed to differentiate between cancer cells and healthy cells, could attract interest from oncology centers seeking cutting-edge solutions for their patients.

Stealth Mode Emergence Emerging from stealth mode with a $57M Series A funding, A2 Biotherapeutics has positioned itself as a key player in the biotech industry. This transition can create buzz within the market, drawing attention from potential clients and collaborators eager to engage with a rising star in cancer therapeutics.

Similar companies to A2 Biotherapeutics, Inc.

✕

Access Insights for A2 Biotherapeutics, Inc. and Millions of Other Companies

Sign up for full access to A2 Biotherapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

A2 Biotherapeutics, Inc. Tech Stack

A2 Biotherapeutics, Inc. uses 8 technology products and services including Fastly, Google Cloud, RequireJS, and more. Explore A2 Biotherapeutics, Inc.'s tech stack below.

  • Fastly
    Content Delivery Network
  • Google Cloud
    Infrastructure As A Service
  • RequireJS
    Javascript Frameworks
  • React
    Javascript Frameworks
  • Slick
    Javascript Libraries
  • Zepto
    Javascript Libraries
  • Java
    Programming Languages
  • Bootstrap
    UI Frameworks

Media & News

A2 Biotherapeutics, Inc.'s Email Address Formats

A2 Biotherapeutics, Inc. uses at least 2 format(s):
A2 Biotherapeutics, Inc. Email FormatsExamplePercentage
FLast@a2bio.comJDoe@a2bio.com
46%
Last@a2bio.comDoe@a2bio.com
7%
FMiddleLast@a2bio.comJMichaelDoe@a2bio.com
1%
FLast@a2bio.comJDoe@a2bio.com
46%
FLast@a2biotherapeutics.comJDoe@a2biotherapeutics.com
97%
FMiddleLast@a2biotherapeutics.comJMichaelDoe@a2biotherapeutics.com
2%
LFirst@a2biotherapeutics.comDJohn@a2biotherapeutics.com
1%

Frequently Asked Questions

Where is A2 Biotherapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s main headquarters is located at 30301 Agoura Road Suite 210 Agoura Hills, CA 91301 US. The company has employees across 1 continents, including North America.

What is A2 Biotherapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s official website is a2bio.com and has social profiles on LinkedIn.

How much revenue does A2 Biotherapeutics, Inc. generate?

Minus sign iconPlus sign icon As of November 2024, A2 Biotherapeutics, Inc.'s annual revenue reached $35M.

What is A2 Biotherapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does A2 Biotherapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of November 2024, A2 Biotherapeutics, Inc. has approximately 138 employees across 1 continents, including North America. Key team members include Chief Executive Officer: J. R.Chief Medical Officer: W. G.Chief Financial Officer: T. L.. Explore A2 Biotherapeutics, Inc.'s employee directory with LeadIQ.

What industry does A2 Biotherapeutics, Inc. belong to?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc. operates in the Biotechnology Research industry.

What technology does A2 Biotherapeutics, Inc. use?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s tech stack includes FastlyGoogle CloudRequireJSReactSlickZeptoJavaBootstrap.

What is A2 Biotherapeutics, Inc.'s email format?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s email format typically follows the pattern of . Find more A2 Biotherapeutics, Inc. email formats with LeadIQ.

How much funding has A2 Biotherapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of November 2024, A2 Biotherapeutics, Inc. has raised $62M in funding. The last funding round occurred on Dec 19, 2022 for $62M.

When was A2 Biotherapeutics, Inc. founded?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc. was founded in 2018.
A2 Biotherapeutics, Inc.

A2 Biotherapeutics, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors.

A2 engineers T cells that target the loss of genetic material in tumors, enabling the selective killing of tumor cells while leaving normal cells unharmed.

The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and has raised $136M since inception. Our investors include The Column Group, Vida Ventures, Samsara BioCapital, Nextech Invest, Casdin Capital, Euclidean Capital, UC Investments (Office of the Chief Investment Officer of the Regents) and Hartford HealthCare Endowment.

✕

Access Insights for A2 Biotherapeutics, Inc. and Millions of Other Companies

Sign up for full access to A2 Biotherapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
30301 Agoura Road Suite 210 Agoura Hills, CA 91301 US
Website
a2bio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $62M

    A2 Biotherapeutics, Inc. has raised a total of $62M of funding over 4 rounds. Their latest funding round was raised on Dec 19, 2022 in the amount of $62M.

  • $10M$50M

    A2 Biotherapeutics, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $62M

    A2 Biotherapeutics, Inc. has raised a total of $62M of funding over 4 rounds. Their latest funding round was raised on Dec 19, 2022 in the amount of $62M.

  • $10M$50M

    A2 Biotherapeutics, Inc.'s revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for A2 Biotherapeutics, Inc. and Millions of Other Companies

Sign up for full access to A2 Biotherapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.